Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

IRTC

iRhythm Technologies Inc

May 03 • 04:00PM ET

102.68

Dollar change -8.20
Percentage change -7.40	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB IWM VXF VBK IWO IHI ROBO SCHA VTWO

Index	RUT	P/E	-	EPS (ttm)	-4.22	Insider Own	1.79%	Shs Outstand	30.95M	Perf Week	-8.25%
Market Cap	3.19B	Forward P/E	-	EPS next Y	-2.10	Insider Trans	-9.19%	Shs Float	30.55M	Perf Month	-4.31%
Income	-129.96M	PEG	-	EPS next Q	-0.93	Inst Own	106.31%	Short Float	9.21%	Perf Quarter	-14.35%
Sales	513.17M	P/S	6.22	EPS this Y	18.40%	Inst Trans	0.45%	Short Ratio	6.00	Perf Half Y	30.11%
Book/sh	2.90	P/B	35.36	EPS next Y	36.24%	ROA	-19.52%	Short Interest	2.81M	Perf Year	-22.81%
Cash/sh	18.30	P/C	5.61	EPS next 5Y	-	ROE	-83.28%	52W Range	70.24 - 134.45	Perf YTD	-4.07%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-13.90%	ROI	-16.01%	52W High	-23.63%	Beta	1.30
Dividend TTM	-	Quick Ratio	6.95	Sales past 5Y	27.64%	Gross Margin	66.96%	52W Low	46.18%	ATR (14)	4.57
Dividend Ex-Date	-	Current Ratio	7.10	EPS Y/Y TTM	-21.54%	Oper. Margin	-21.96%	RSI (14)	35.71	Volatility	4.84% 3.94%
Employees	2000	Debt/Eq	8.16	Sales Y/Y TTM	19.35%	Profit Margin	-25.33%	Recom	1.25	Target Price	137.50
Option/Short	Yes / Yes	LT Debt/Eq	7.99	EPS Q/Q	-14.01%	Payout	-	Rel Volume	1.91	Prev Close	110.88
Sales Surprise	2.74%	EPS Surprise	-51.14%	Sales Q/Q	18.39%	Earnings	May 02 AMC	Avg Volume	468.69K	Price	102.68
SMA20	-8.57%	SMA50	-7.50%	SMA200	1.04%	Trades		Volume	887,487	Change	-7.40%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-11-23	Upgrade	Citigroup	Neutral → Buy	$110
Jul-19-23	Initiated	Robert W. Baird	Outperform	$130
Feb-07-23	Initiated	Wells Fargo	Overweight	$150
Nov-07-22	Upgrade	Wolfe Research	Underperform → Peer Perform
Jun-09-22	Downgrade	Citigroup	Buy → Neutral	$180 → $155
Apr-06-22	Initiated	Wolfe Research	Underperform	$105
Feb-24-22	Upgrade	Needham	Hold → Buy	$135
Feb-24-22	Upgrade	Needham	Hold → Buy
Jan-18-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$129 → $167
Jan-12-22	Upgrade	BTIG Research	Neutral → Buy	$170
Jan-11-22	Upgrade	Oppenheimer	Perform → Outperform	$150
Dec-21-21	Resumed	Canaccord Genuity	Buy	$125
Dec-17-21	Upgrade	JP Morgan	Neutral → Overweight	$100 → $116
Dec-15-21	Upgrade	Citigroup	Neutral → Buy	$120
Jun-02-21	Downgrade	Citigroup	Buy → Neutral	$105 → $78
Apr-13-21	Downgrade	BTIG Research	Buy → Neutral
Apr-12-21	Downgrade	JP Morgan	Overweight → Neutral
Feb-26-21	Downgrade	Colliers Securities	Buy → Neutral
Jan-29-21	Reiterated	Needham	Hold
Nov-17-20	Downgrade	Oppenheimer	Outperform → Perform

Show Previous Ratings

May-05-24 08:36AM	iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-03-24 10:05AM	Needham Adjusts iRhythm Technologies' PT to $138 From $137, Says 'Strong' Q1 Revenue Growth Should Continue; Keeps Buy Rating (MT Newswires) -7.40%
07:05AM	Q1 2024 iRhythm Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-24 10:54PM	IRTC Stock Earnings: iRhythm Technologies Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:39PM	iRhythm Technologies Reports Q1 2024 Results: Revenue Surpasses Estimates Amidst Wider Losses (GuruFocus.com)
04:05PM	Loading…
04:05PM	iRhythm Technologies Announces First Quarter 2024 Financial Results (GlobeNewswire)
09:45AM	NASDAQ: IRTC Lawsuit Notice: Investors who lost money with iRhythm Technologies, Inc. (NASDAQ: IRTC) shares should contact the Shareholders Foundation (GlobeNewswire)
Apr-23-24 12:35PM	What Makes iRhythm Technologies (IRTC) a Lucrative Investment? (Insider Monkey)
Apr-18-24 04:05PM	iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024 (GlobeNewswire)
Apr-08-24 04:09AM	iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains? (Zacks)
Apr-01-24 05:45AM	iRhythm Technologies, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - IRTC (PR Newswire)
Mar-20-24 05:45AM	iRhythm Technologies, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights - IRTC (PR Newswire)
Mar-13-24 11:30AM	SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm (PR Newswire)
Mar-08-24 04:30PM	iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers' $86.25 Million Option to Purchase Additional Notes (GlobeNewswire)
Mar-05-24 11:29PM	Insider Sell: EVP, CMO & CSO Minang Turakhia Sells 943 Shares of iRhythm Technologies Inc (IRTC) (GuruFocus.com)
11:42PM	Loading…
Mar-04-24 11:42PM	iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029 (GlobeNewswire) -9.52%
06:45AM	iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes (GlobeNewswire)
Feb-29-24 04:30PM	iRhythm collaborates with Epic to streamline access to Zio service and drive more seamless connectivity between clinicians and patients (GlobeNewswire)
Feb-23-24 12:30PM	IRHYTHM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options (GlobeNewswire) -8.69%
11:06AM	iRhythm Technologies, Inc. (NASDAQ:IRTC) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:45AM	iRhythm Technologies, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights - IRTC (PR Newswire)
Feb-22-24 05:50PM	IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:36PM	iRhythm Technologies Inc (IRTC) Reports Growth Amidst Challenges in Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-20-24 01:59PM	IRTC SHAREHOLDERS: Shareholders with Significant Losses Should Contact Robbins LLP For Information About Their Rights and Remedies (Business Wire)
05:45AM	Investors in iRhythm Technologies, Inc. Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights - IRTC (PR Newswire)
Feb-08-24 04:05PM	iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 (GlobeNewswire)
Jan-14-24 12:54PM	7 Healthcare Stocks Taking Medicine to the Next Level (InvestorPlace)
Jan-08-24 08:30AM	iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +7.28%
Jan-05-24 08:05AM	Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service (GlobeNewswire)
07:01PM	Loading…
Jan-04-24 07:01PM	iRhythm Technologies Inc Insider Sells Company Shares (GuruFocus.com)
Jan-03-24 08:00AM	iRhythm Technologies Receives European Union's CE Marking Under Medical Device Regulation (EU MDR) for its Zio monitor and ZEUS System (GlobeNewswire)
Dec-26-23 04:30PM	iRhythm Technologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-13-23 08:05AM	New Research Presented at American Heart Association's 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization (GlobeNewswire)
Nov-03-23 10:41AM	iRhythm Technologies, Inc. (NASDAQ:IRTC) Q3 2023 Earnings Call Transcript (Insider Monkey) +5.20%
09:44AM	Q3 2023 iRhythm Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-02-23 06:22PM	iRhythm Technologies Inc (IRTC) Reports 20% Revenue Growth in Q3 2023 (GuruFocus.com)
04:05PM	iRhythm Technologies Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-31-23 10:01AM	Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-27-23 09:35AM	Down -23.87% in 4 Weeks, Here's Why iRhythm Technologies (IRTC) Looks Ripe for a Turnaround (Zacks) +6.89%
Oct-26-23 10:02AM	IRhythm Technologies (IRTC) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-19-23 04:05PM	iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023 (GlobeNewswire)
Sep-28-23 08:23AM	iRhythm Technologies (IRTC) Moves 7.4% Higher: Will This Strength Last? (Zacks) +5.29%
Sep-27-23 07:35PM	Unveiling iRhythm Technologies (IRTC)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com) +7.40%
Sep-26-23 08:05AM	iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor (GlobeNewswire)
Sep-22-23 11:47AM	Unveiling iRhythm Technologies (IRTC)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Aug-29-23 08:30AM	iRhythm Technologies to Participate in Two Investor Conferences in September (GlobeNewswire)
Aug-23-23 06:00AM	Revolutionizing Tech: 7 Growth Stocks to Grab for Dynamic Returns (InvestorPlace)
Aug-04-23 10:45AM	Is iRhythm Technologies, Inc. (NASDAQ:IRTC) Potentially Undervalued? (Simply Wall St.) +18.26%
Aug-03-23 05:55PM	IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:10PM	Zio Granted High Medical Needs Designation by the Japanese Ministry of Health, Labour, and Welfare (GlobeNewswire)
04:05PM	iRhythm Technologies Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:24PM	Biotech Stocks Join AI-Fueled Rally (The Wall Street Journal)
Jul-20-23 04:05PM	iRhythm Technologies to Report Second Quarter 2023 Financial Results on August 3, 2023 (GlobeNewswire)
Jul-18-23 08:30AM	NAMCP Independent Third-Party Review Validates Value Proposition of iRhythm Zio XT Service to Health Systems and Payers (GlobeNewswire)
Jun-14-23 09:23AM	Schrodinger, Inc. (SDGR) Surges 6.6%: Is This an Indication of Further Gains? (Zacks)
Jun-06-23 09:00AM	iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments (GlobeNewswire)
May-27-23 08:28AM	Investors push iRhythm Technologies (NASDAQ:IRTC) 6.9% lower this week, company's increasing losses might be to blame (Simply Wall St.)
May-24-23 04:05PM	iRhythm Technologies to Present at the William Blair 43rd Annual Growth Stock Conference (GlobeNewswire)
May-22-23 08:30AM	New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias (GlobeNewswire)
May-11-23 06:09AM	The 3 Best MedTech Stocks to Watch in May 2023 (InvestorPlace)
May-04-23 06:05PM	IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	iRhythm Technologies Announces First Quarter 2023 Financial Results (GlobeNewswire)
Apr-20-23 04:05PM	iRhythm Technologies to Report First Quarter 2023 Financial Results on May 4, 2023 (GlobeNewswire)
Apr-14-23 06:51PM	3 Thrilling Robotics Stocks for Aggressive Investors to Buy (InvestorPlace)
Apr-13-23 12:21PM	Estimating The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC) (Simply Wall St.)
Apr-12-23 04:30PM	iRhythm Technologies Releases 2022 Environmental, Social, and Governance Report Reflecting Strategy to Deliver Purpose-Driven Growth (GlobeNewswire)
Apr-02-23 02:07PM	The 7 Best Robotics Stocks to Buy for Long-Term Growth (InvestorPlace)
Mar-14-23 07:42AM	iRhythm Technologies (IRTC) Soars 3.9%: Is Further Upside Left in the Stock? (Zacks)
Mar-06-23 08:30AM	Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors (GlobeNewswire)
Mar-02-23 08:30AM	Four New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC (GlobeNewswire)
Feb-25-23 08:04AM	Should You Think About Buying iRhythm Technologies, Inc. (NASDAQ:IRTC) Now? (Simply Wall St.)
Feb-24-23 02:44PM	iRhythm's Q4 Earnings Beat Expectations, Analysts Remain Bullish On Upcoming Catalysts (Benzinga) +8.33%
Feb-23-23 04:05PM	iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-21-23 06:57AM	What Makes iRhythm Technologies (IRTC) Stock an Attractive Investment? (Insider Monkey)
Feb-09-23 04:05PM	iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 (GlobeNewswire)
Jan-09-23 08:30AM	iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-27-22 04:30PM	iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.60%
Dec-01-22 01:54PM	iRhythm Technologies' (NASDAQ:IRTC) growing losses don't faze investors as the stock advances 3.4% this past week (Simply Wall St.)
Nov-14-22 10:43AM	Should You Consider iRhythm Technologies (IRTC) Shares for Investment? (Insider Monkey)
Nov-07-22 04:05PM	Results of Four Studies Demonstrating Clinical, Economic Value of iRhythms Product Portfolio Presented at American Heart Association 22 (GlobeNewswire)
Nov-06-22 12:30PM	New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective (GlobeNewswire)
Nov-04-22 11:47AM	Calculating The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC) (Simply Wall St.)
Nov-02-22 05:45PM	iRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023 (GlobeNewswire)
08:30AM	iRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023 (GlobeNewswire)
06:28AM	iRhythm Posts Smaller Than Expected Loss In Q3, But Shares Fall On Lowered Annual Guidance (Benzinga)
Nov-01-22 05:45PM	IRhythm Technologies (IRTC) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	iRhythm Technologies Announces Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-20-22 04:05PM	iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022 (GlobeNewswire)
Sep-21-22 08:30AM	iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day (GlobeNewswire) -14.80%
Aug-31-22 08:30AM	iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022 (GlobeNewswire)
Aug-06-22 05:00AM	iRhythm Technologies, Inc. Common Stock (IRTC) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-05-22 10:27AM	iRhythm Reports Smaller Than Expected Q2 Loss; Narrows Annual Sales Guidance (Benzinga)
Aug-04-22 07:15PM	IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	iRhythm Technologies Announces Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-28-22 04:30PM	iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire)
10:02AM	Analysts Estimate iRhythm Technologies (IRTC) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-25-22 04:15PM	iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence (GlobeNewswire)
Jul-22-22 04:52PM	Verily, iRhythm watch cleared to track irregular heart beat (American City Business Journals)
08:30AM	iRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System (GlobeNewswire)

iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Blackford Quentin S.	President and CEO	Mar 04 '24	Sale	111.14	4,221	469,122	175,794	Mar 05 04:52 PM
Day Mark J.	Chief Technology Officer	Mar 04 '24	Sale	111.14	3,248	360,983	61,164	Mar 05 04:53 PM
Wilson Daniel G.	EVP, Corp Dev Inv Rel	Mar 04 '24	Sale	111.14	2,452	272,515	30,515	Mar 05 04:50 PM
Bobzien Brice	Chief Financial Officer	Mar 04 '24	Sale	111.14	1,401	155,707	25,800	Mar 05 04:50 PM
Patterson Chad	Chief Commercial Officer	Mar 04 '24	Sale	111.14	1,077	119,698	39,865	Mar 05 04:52 PM
Turakhia Minang	EVP, CMO & CSO	Mar 04 '24	Sale	111.14	943	104,805	28,659	Mar 05 04:50 PM
Shrishrimal Sumi	EVP, Chief Risk Officer	Mar 04 '24	Sale	111.14	723	80,354	24,429	Mar 05 04:49 PM
Blackford Quentin S.	President and CEO	Feb 29 '24	Sale	121.96	24,701	3,012,534	180,015	Mar 01 07:19 PM
Murphy Patrick Michael	CBO and CLO	Feb 29 '24	Sale	121.96	7,615	928,725	48,962	Mar 01 07:19 PM
Day Mark J.	Chief Technology Officer	Feb 29 '24	Sale	121.96	1,475	179,891	64,412	Mar 01 07:18 PM
Wilson Daniel G.	EVP, Corp Dev Inv Rel	Feb 29 '24	Sale	121.96	1,261	153,792	32,967	Mar 01 07:18 PM
Wilson Daniel G.	EVP, Corp Dev Inv Rel	Jan 02 '24	Sale	103.31	7,218	745,692	26,629	Jan 04 11:57 AM
Bobzien Brice	Chief Financial Officer	Aug 09 '23	Sale	111.29	1,356	150,909	18,608	Aug 10 04:20 PM
Day Mark J.	Chief Technology Officer	Aug 03 '23	Option Exercise	36.22	486	17,603	55,522	Aug 04 08:48 AM
Shrishrimal Sumi	EVP, Chief Risk Officer	Jun 02 '23	Sale	111.45	1,109	123,598	18,707	Jun 05 04:07 PM

Open in Screener

DXCM

Dexcom Inc

May 03 • 04:00PM ET

128.37

Dollar change +1.72
Percentage change 1.36	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VO QQQ VUG IVV VOT IHI IWP VHT

Index	NDX, S&P 500	P/E	82.87	EPS (ttm)	1.55	Insider Own	2.10%	Shs Outstand	397.68M	Perf Week	3.24%
Market Cap	51.05B	Forward P/E	56.94	EPS next Y	2.25	Insider Trans	-3.28%	Shs Float	391.29M	Perf Month	-3.73%
Income	639.30M	PEG	2.31	EPS next Q	0.39	Inst Own	95.95%	Short Float	3.01%	Perf Quarter	6.13%
Sales	3.80B	P/S	13.43	EPS this Y	17.84%	Inst Trans	-0.34%	Short Ratio	3.69	Perf Half Y	36.38%
Book/sh	5.67	P/B	22.63	EPS next Y	25.87%	ROA	10.66%	Short Interest	11.77M	Perf Year	9.42%
Cash/sh	7.28	P/C	17.62	EPS next 5Y	35.90%	ROE	28.54%	52W Range	74.75 - 142.00	Perf YTD	3.45%
Dividend Est.	-	P/FCF	87.49	EPS past 5Y	-	ROI	13.27%	52W High	-9.60%	Beta	1.25
Dividend TTM	-	Quick Ratio	2.53	Sales past 5Y	28.80%	Gross Margin	62.79%	52W Low	71.73%	ATR (14)	4.65
Dividend Ex-Date	-	Current Ratio	2.90	EPS Y/Y TTM	119.82%	Oper. Margin	17.14%	RSI (14)	44.41	Volatility	3.19% 3.58%
Employees	9600	Debt/Eq	1.15	Sales Y/Y TTM	25.78%	Profit Margin	16.82%	Recom	1.36	Target Price	152.94
Option/Short	Yes / Yes	LT Debt/Eq	1.14	EPS Q/Q	198.58%	Payout	0.00%	Rel Volume	0.55	Prev Close	126.65
Sales Surprise	1.22%	EPS Surprise	18.26%	Sales Q/Q	24.21%	Earnings	Apr 25 AMC	Avg Volume	3.19M	Price	128.37
SMA20	-4.09%	SMA50	-2.34%	SMA200	11.74%	Trades		Volume	1,778,982	Change	1.36%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142
Jan-26-23	Initiated	Wolfe Research	Outperform	$121
Oct-18-22	Initiated	Barclays	Equal Weight	$103
Oct-12-22	Initiated	Jefferies	Buy	$125
Jul-15-22	Initiated	Bernstein	Outperform	$105
Mar-02-22	Resumed	BofA Securities	Buy	$500
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$535
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$575
Jan-07-22	Upgrade	Guggenheim	Neutral → Buy	$580
Oct-18-21	Downgrade	Guggenheim	Buy → Neutral
Jul-21-21	Resumed	Cowen	Outperform	$540 → $525
May-28-21	Upgrade	Wells Fargo	Underweight → Equal Weight	$380
May-25-21	Initiated	Barclays	Overweight	$500
Apr-15-21	Initiated	Atlantic Equities	Overweight	$438
Jan-06-21	Upgrade	UBS	Neutral → Buy	$410 → $445
Oct-02-20	Downgrade	Wells Fargo	Equal Weight → Underweight	$420 → $350
May-27-20	Reiterated	Piper Sandler	Overweight	$375 → $450

Show Previous Ratings

May-04-24 06:18AM	3 Internet of Things (IoT) Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace)
May-03-24 10:00AM	Shhh! 3 Secret IoT Stocks Flying Below Wall Street's Radar (InvestorPlace)
Apr-30-24 03:03PM	Dexcom Stock Continues To Post Very Healthy Profits, Returns (Investor's Business Daily)
12:45PM	Here is Why Growth Investors Should Buy DexCom (DXCM) Now (Zacks)
10:31AM	DexCom, Inc. (NASDAQ:DXCM) Q1 2024 Earnings Call Transcript (Insider Monkey)
09:00AM	Loading…
09:00AM	DexCom, Inc. (DXCM) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Apr-29-24 09:45AM	Here's Why DexCom (DXCM) is a Strong Growth Stock (Zacks)
Apr-26-24 04:11PM	Dexcom Plummets After Raising Its Sales Guidance For The Year But Not Enough (Investor's Business Daily) -9.91%
03:09PM	ABT, DHR, DXCM: Which Strong Buy Healthcare Stock Has More Upside? (TipRanks)
11:37AM	Analyst Report: DexCom, Inc. (Morningstar Research)
11:08AM	Morgan Stanley Adjusts DexCom's Price Target to $132 From $122 (MT Newswires)
10:53AM	Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144 (MT Newswires)
10:25AM	Raymond James Adjusts DexCom Price Target to $160 From $151 (MT Newswires)
07:29AM	DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues (Zacks)
07:09AM	Q1 2024 Dexcom Inc Earnings Call (Thomson Reuters StreetEvents)
01:30AM	Loading…
01:30AM	DexCom (DXCM) Q1 2024 Earnings Call Transcript (Motley Fool)
01:03AM	Decoding DexCom Inc (DXCM): A Strategic SWOT Insight (GuruFocus.com)
Apr-25-24 08:56PM	DXCM Stock Earnings: DexCom Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:29PM	Dexcom's profit beats estimates on strong glucose monitor demand (Reuters)
06:00PM	DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:56PM	13 Best Growth Stocks To Invest In For the Next 5 Years (Insider Monkey)
05:43PM	DexCom Inc (DXCM) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance (GuruFocus.com)
04:43PM	DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours (MT Newswires)
04:15PM	DexCom: Q1 Earnings Snapshot (Associated Press Finance)
04:12PM	Dexcom Beats First-Quarter Views And Raises Sales Outlook, But Shares Crumble (Investor's Business Daily)
04:03PM	Dexcom Reports First Quarter 2024 Financial Results (Business Wire)
11:34AM	20 Fastest Growing Health Tech Companies in the World (Insider Monkey)
Apr-24-24 09:30AM	Wall Street Bulls Look Optimistic About DexCom (DXCM): Should You Buy? (Zacks)
Apr-23-24 09:29AM	DexCom (DXCM) to Report Q1 Earnings: What's in the Cards? (Zacks)
06:14AM	Boston Scientific, Dexcom and Edwards next as earnings season rolls on (MedTech Dive)
09:16AM	Loading…
Apr-22-24 09:16AM	Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Apr-21-24 10:49AM	11 Hot Growth Stocks To Buy Right Now (Insider Monkey)
Apr-19-24 02:39PM	Even IBD 50 Medical Products Stocks Don't All Look Healthy In This Sick Market (Investor's Business Daily)
08:30AM	Dexcom In Buy Zone After Launch Of Prescription-Free Diabetes Monitor; Earnings Due Next Week (Investor's Business Daily)
Apr-18-24 08:26AM	Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now (Zacks)
Apr-16-24 07:00PM	EVP Strategy and Corporate Dev Matthew Dolan Sells Shares of DexCom Inc (DXCM) (GuruFocus.com)
04:13AM	14 Best 52-Week High Stocks To Invest In Now (Insider Monkey)
Apr-15-24 06:15PM	DexCom (DXCM) Stock Moves -1.16%: What You Should Know (Zacks)
10:54AM	DexCom (DXCM), MD Revolution Unite to Boost Diabetes Management (Zacks)
Apr-12-24 08:00AM	Why Wall Street Got Even More Excited About The Glucose Monitor And How Dexcom, Abbott Labs Stand To Benefit (Investor's Business Daily)
Apr-11-24 09:40AM	Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? (Zacks)
Apr-10-24 07:00PM	Insider Sell: DexCom Inc (DXCM) President, CEO and Chairman Kevin Sayer Sells 49,633 Shares (GuruFocus.com)
04:00PM	Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In (InvestorPlace)
03:41PM	3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild (InvestorPlace)
09:27AM	This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives? (MarketWatch)
Apr-08-24 06:00PM	Why the Market Dipped But DexCom (DXCM) Gained Today (Zacks)
02:44PM	DexCom Stock Sees IBD Stock Market Rating Sweetens Ups; Earns 83 RS Rating (Investor's Business Daily)
08:30AM	2 Growth Stocks to Buy Hand Over Fist in April (Motley Fool)
Apr-04-24 09:00AM	DexCom, Inc. (DXCM) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-03-24 10:14AM	Jim Cramer is Talking About Trump Media and 10 Other Stocks (Insider Monkey)
09:00AM	Dexcom Publishes Annual Sustainability Report (Business Wire)
Apr-02-24 06:00PM	DexCom (DXCM) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
08:30AM	Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time (Business Wire)
Apr-01-24 04:48PM	3 Overvalued S&P 500 Stocks for Your Do NOT Buy List (InvestorPlace)
Mar-30-24 01:55AM	Insider Sell: EVP Chief Legal Officer Michael Brown Sells 2,624 Shares of DexCom Inc (DXCM) (GuruFocus.com)
Mar-29-24 12:00PM	DexCom (DXCM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
01:44AM	Should You Hold DexCom (DXCM)? (Insider Monkey)
Mar-27-24 03:03PM	Diabetes Play Dexcom Tops Buy Point After FDA Clears Device Likely To Be Used For Weight Loss (Investor's Business Daily)
10:56AM	DexCom (DXCM) Hits 52-Week High: What's Driving the Stock? (Zacks)
07:02AM	Here's What Happened to Dexcom (DXCM) Stock in Q4 (Insider Monkey)
Mar-26-24 07:00PM	Insider Sell: EVP Chief Human Resources Sadie Stern Sells 4,137 Shares of DexCom Inc (DXCM) (GuruFocus.com)
06:00PM	DexCom (DXCM) Stock Moves -0.12%: What You Should Know (Zacks)
01:56PM	Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good. (Investor's Business Daily)
09:40AM	Has DexCom (DXCM) Outpaced Other Medical Stocks This Year? (Zacks)
08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
05:10AM	32 Countries with the Highest Rates of Diabetes (Insider Monkey)
Mar-25-24 04:21PM	Two Hot AI Stocks Lead S&P 500 Monday (Investor's Business Daily) +5.20%
04:21PM	AI Stocks Super Micro, Micron Lead S&P 500 Monday (Investor's Business Daily)
Mar-23-24 08:00AM	S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind (Investor's Business Daily)
Mar-21-24 09:00AM	DexCom, Inc. (DXCM) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-20-24 07:44PM	25 Countries With Limited Access To Healthcare (Insider Monkey)
04:02AM	Should You Hold DexCom (DXCM) for the Long Term? (Insider Monkey)
Mar-19-24 07:00PM	Insider Sell: EVP Strategy & Corporate Development Matthew Dolan Sells Shares of DexCom Inc ... (GuruFocus.com)
06:00PM	DexCom (DXCM) Stock Sinks As Market Gains: Here's Why (Zacks)
Mar-18-24 02:47PM	DexCom Stock Trying To Close In On Key Technical Benchmark (Investor's Business Daily)
09:29AM	Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now (Zacks)
08:55AM	TipRanks Perfect 10 List: Analysts Pound the Table on These Top-Scoring Stocks (TipRanks)
Mar-14-24 09:30AM	Is It Worth Investing in DexCom (DXCM) Based on Wall Street's Bullish Views? (Zacks)
Mar-13-24 04:43PM	IBD Stock Of The Day Dexcom Lingers In Buy Zone As Diabetes Play Eyes Obesity Market (Investor's Business Daily)
Mar-11-24 06:00PM	DexCom (DXCM) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Mar-08-24 09:15AM	2 Medical Device Stocks to Buy Hand Over Fist in March (Motley Fool)
07:57AM	DexCom's (DXCM) Direct-to-Watch Feature to Boost Its G7 System (Zacks)
05:41AM	DexCom (DXCM) Soars 10% This Week: What's Fueling the Gain? (Zacks)
Mar-07-24 09:40AM	Are Medical Stocks Lagging DexCom (DXCM) This Year? (Zacks)
09:00AM	Investors Heavily Search DexCom, Inc. (DXCM): Here is What You Need to Know (Zacks)
08:00AM	Should You Add Quanta Services (PWR) to Your Portfolio? (Insider Monkey)
07:37AM	Does Jabil (JBL) Have a Compelling Profit Cycle? (Insider Monkey)
06:38AM	Should You Hold Shopify (SHOP) for the Long Term? (Insider Monkey)
06:29AM	Here's Why DexCom (DXCM) Outperformed in Q4 (Insider Monkey)
06:20AM	Factors that Enabled Chipotle Mexican Grill (CMG) to Pass Through Food Inflation (Insider Monkey)
05:27AM	Dexcoms over-the-counter nod sets stage for broader CGM use (MedTech Dive)
03:43AM	DexCom (DXCM) Soars 9.8%: Is Further Upside Left in the Stock? (Zacks)
Mar-06-24 07:03PM	Analyst Report: DexCom, Inc. (Morningstar Research) +9.80%
05:18PM	S&P 500 Gains and Losses Today: Dexcom Soars as FDA Approves New Glucose Monitor (Investopedia)
04:50PM	Dexcom Gets FDA Clearance for OTC Glucose Monitor, and Stock Jumps (Investopedia)
04:15PM	Dexcom Breaks Out As FDA Clears It To Enter A New Market: Obesity (Investor's Business Daily)
02:58PM	Final Trades: SL Green, Palantir and Dexcom (CNBC TV)
01:08PM	Top Stock Movers Now: CrowdStrike, Dexcom, Brown-Forman, and More (Investopedia)
11:36AM	Dexcom Flashes A Bullish Sign As FDA Clearance Allows It To Enter A New Market: Obesity (Investor's Business Daily)
10:25AM	Why Dexcom And The Obesity Market Could Benefit From This New FDA Win (Investor's Business Daily)

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brown Michael Jon	EVP Chief Legal Officer	Apr 30 '24	Sale	126.25	629	79,411	68,212	May 02 05:07 PM
Dolan Matthew Vincent	EVP Strategy and Corporate Dev	Apr 15 '24	Sale	137.81	1,990	274,242	42,377	Apr 16 04:16 PM
SAYER KEVIN R	President CEO and Chairman	Apr 08 '24	Sale	138.30	49,633	6,864,136	283,893	Apr 10 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Mar 28 '24	Sale	140.04	2,624	367,472	68,682	Mar 29 07:30 PM
Stern Sadie	EVP Chief Human Resources	Mar 25 '24	Sale	140.00	4,137	579,180	76,304	Mar 26 04:46 PM
Dolan Matthew Vincent	EVP Strategy & Corp Dev	Mar 15 '24	Sale	130.21	4,203	547,259	44,367	Mar 19 04:55 PM
SAYER KEVIN R	President CEO and Chairman	Mar 12 '24	Sale	133.36	81,007	10,802,803	333,526	Mar 14 05:40 PM
Stern Sadie	EVP Chief Human Resources	Mar 12 '24	Sale	133.61	20,321	2,715,006	80,441	Mar 14 05:40 PM
Leach Jacob Steven	EVP Chief Operating Officer	Mar 12 '24	Sale	134.41	14,639	1,967,638	273,913	Mar 14 05:40 PM
Sylvain Jereme M	EVP Chief Financial Officer	Mar 12 '24	Sale	134.41	11,661	1,567,363	85,534	Mar 14 05:40 PM
Brown Michael Jon	EVP Chief Legal Officer	Mar 12 '24	Sale	134.41	8,799	1,182,680	71,306	Mar 14 05:39 PM
Dolan Matthew Vincent	EVP Strategy and Corporate	Mar 12 '24	Sale	134.41	6,710	901,896	48,570	Mar 14 05:39 PM
Lawver Teri L	EVP Chief Commercial Officer	Mar 12 '24	Sale	134.41	4,764	640,333	66,641	Mar 14 05:39 PM
Sylvain Jereme M	EVP Chief Financial Officer	Feb 20 '24	Sale	116.73	3,363	392,563	71,142	Feb 21 05:48 PM
SAYER KEVIN R	President, CEO and Chairman	Jan 16 '24	Sale	123.63	37,325	4,614,669	362,841	Jan 17 06:49 PM
Leach Jacob Steven	EVP Chief Operating Officer	Jan 16 '24	Sale	123.63	3,978	491,819	262,499	Jan 17 06:49 PM
Stern Sadie	EVP Chief Human Resources	Jan 16 '24	Sale	123.63	2,902	358,788	79,051	Jan 17 06:56 PM
Sylvain Jereme M	EVP Chief Financial Officer	Jan 16 '24	Sale	123.63	2,734	338,018	74,505	Jan 17 06:54 PM
ALTMAN STEVEN R	Director	Jan 16 '24	Sale	122.86	1,568	192,652	53,132	Jan 17 06:47 PM
AUGUSTINOS NICHOLAS	Director	Dec 15 '23	Sale	123.02	3,976	489,128	34,040	Dec 18 04:32 PM
ALTMAN STEVEN R	Director	Dec 15 '23	Sale	122.77	2,000	245,548	54,700	Dec 18 04:31 PM
ALTMAN STEVEN R	Director	Dec 12 '23	Sale	120.00	3,000	360,004	56,700	Dec 13 04:18 PM
Stern Sadie	EVP Chief Human Resources Offi	Dec 11 '23	Sale	117.66	392	46,123	76,008	Dec 11 06:15 PM
Brown Michael Jon	EVP Chief Legal Officer	Dec 01 '23	Sale	114.56	3,612	413,774	58,394	Dec 04 06:10 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Nov 24 '23	Sale	110.80	411	45,539	124,775	Nov 27 04:00 PM
Stern Sadie	EVP Chief Human Resources Offi	Nov 22 '23	Sale	110.00	1,176	129,360	76,400	Nov 24 03:51 PM
ALTMAN STEVEN R	Director	Nov 15 '23	Sale	101.26	1,000	101,256	59,700	Nov 15 06:36 PM
Naganathan Girish	EVP Chief Technology Officer	Nov 09 '23	Sale	93.27	2,725	254,161	47,725	Nov 27 07:34 PM
Regan Barry J.	EVP Operations	Nov 08 '23	Sale	95.22	2,019	192,249	64,250	Nov 08 04:05 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Oct 23 '23	Sale	85.75	411	35,243	125,186	Oct 23 07:43 PM
ALTMAN STEVEN R	Director	Oct 16 '23	Sale	77.58	1,000	77,580	60,700	Oct 17 04:15 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Sep 22 '23	Sale	88.40	411	36,332	125,597	Sep 22 06:30 PM
ALTMAN STEVEN R	Director	Sep 15 '23	Sale	101.50	1,000	101,495	61,700	Sep 19 04:43 PM
Heller Bridgette P	Director	Sep 12 '23	Sale	106.56	600	63,936	23,731	Sep 13 07:55 PM
Dolan Matthew Vincent	SVP Corporate Strategy-Develop	Sep 01 '23	Sale	102.32	56	5,730	33,569	Sep 01 06:40 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Aug 23 '23	Sale	107.03	411	43,989	126,008	Aug 23 05:42 PM
Sylvain Jereme M	EVP Chief Financial Officer	Aug 22 '23	Sale	104.38	1,844	192,477	72,867	Aug 22 04:04 PM
Stern Sadie	EVP Chief Human Resources Offi	Aug 09 '23	Sale	110.71	392	43,398	81,682	Aug 11 03:59 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jul 24 '23	Sale	130.58	412	53,799	126,419	Jul 24 05:18 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jul 14 '23	Sale	136.00	5,031	684,216	126,831	Jul 17 04:54 PM
Regan Barry J.	EVP Operations	Jul 10 '23	Sale	128.05	1,989	254,691	66,269	Jul 10 05:39 PM
Stern Sadie	EVP Chief Human Resources Offi	Jul 10 '23	Sale	128.05	392	50,196	82,074	Jul 10 05:40 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jun 23 '23	Sale	125.92	412	51,879	131,862	Jun 26 04:16 PM
Selvaraj Shelly Ramasamy	SVP Chief Information Officer	Jun 15 '23	Sale	130.00	2,115	274,953	50,390	Jun 15 05:16 PM
Stern Sadie	EVP Chief Human Resources Offi	Jun 09 '23	Sale	121.31	393	47,675	82,466	Jun 12 04:32 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	May 23 '23	Sale	118.65	412	48,884	132,274	May 23 07:13 PM
Sylvain Jereme M	EVP Chief Financial Officer	May 22 '23	Sale	117.58	2,400	282,192	74,711	May 23 07:12 PM
Stern Sadie	EVP Chief Human Resources Offi	May 09 '23	Sale	120.19	393	47,235	82,859	May 09 06:24 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

IRTC

iRhythm Technologies Inc

DXCM

Dexcom Inc

Upgrade your FINVIZ experience